| Harris B Cohen, MD | |
|
345 N York Rd, Hatboro, PA 19040-2045 | |
| (215) 675-1516 | |
| (215) 675-0901 |
| Full Name | Harris B Cohen |
|---|---|
| Gender | Male |
| Speciality | Family Practice |
| Experience | 24 Years |
| Location | 345 N York Rd, Hatboro, Pennsylvania |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1801887856 | NPI | - | NPPES |
| 01947913-0006 | Medicaid | PA |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207Q00000X | Family Medicine | MD-420052 (Pennsylvania) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| Doylestown Hospital Visiting Nurse/hcd | Doylestown, PA | Home health agency |
| Jefferson Health Home Care And Hospice | Willow grove, PA | Home health agency |
| Doylestown Hospital | Doylestown, PA | Hospital |
| Holy Redeemer Hospital And Medical Center | Meadowbrook, PA | Hospital |
| Abington Memorial Hospital | Abington, PA | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Hatboro Medical Associates, Pc | 6406835198 | 5 |
News Archive
October 29 is World Psoriasis Day. Conceived by patients for patients, World Psoriasis Day is a truly global event focusing on the burden of living with psoriasis. There are more than 125 million people with psoriasis/psoriatic arthritis in the world. Psoriasis is a severe chronic inflammatory disease that effects all ages, genders, races and ethnicities.
Biogen Idec today announced that the U.S. Patent and Trademark Office has granted U.S. Patent No. 8,399,514, which offers additional protection for TECFIDERA (dimethyl fumarate), the company's oral therapeutic candidate for the treatment of multiple sclerosis.
Mallinckrodt announced today that the first clinical data on MNK-795 will be presented at PAINWeek 2013, to be held September 4-7 in Las Vegas. MNK-795 is an extended-release oral formulation of oxycodone and acetaminophen that has been studied in clinical trials for the management of moderate to severe acute pain where the use of an opioid analgesic is appropriate.
On Feb. 27, 2018, I got an email from the Heritage Foundation, alerting me to a news conference that afternoon held by Republican attorneys general of Texas and other states. It was referred to only as a "discussion about the Affordable Care Act lawsuit."
› Verified 6 days ago
| Entity Name | Abington Memorial Hospital |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1235286253 PECOS PAC ID: 3274437736 Enrollment ID: O20040325000619 |
News Archive
October 29 is World Psoriasis Day. Conceived by patients for patients, World Psoriasis Day is a truly global event focusing on the burden of living with psoriasis. There are more than 125 million people with psoriasis/psoriatic arthritis in the world. Psoriasis is a severe chronic inflammatory disease that effects all ages, genders, races and ethnicities.
Biogen Idec today announced that the U.S. Patent and Trademark Office has granted U.S. Patent No. 8,399,514, which offers additional protection for TECFIDERA (dimethyl fumarate), the company's oral therapeutic candidate for the treatment of multiple sclerosis.
Mallinckrodt announced today that the first clinical data on MNK-795 will be presented at PAINWeek 2013, to be held September 4-7 in Las Vegas. MNK-795 is an extended-release oral formulation of oxycodone and acetaminophen that has been studied in clinical trials for the management of moderate to severe acute pain where the use of an opioid analgesic is appropriate.
On Feb. 27, 2018, I got an email from the Heritage Foundation, alerting me to a news conference that afternoon held by Republican attorneys general of Texas and other states. It was referred to only as a "discussion about the Affordable Care Act lawsuit."
› Verified 6 days ago
| Entity Name | Hatboro Medical Associates, Pc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1619958048 PECOS PAC ID: 6406835198 Enrollment ID: O20040716000091 |
News Archive
October 29 is World Psoriasis Day. Conceived by patients for patients, World Psoriasis Day is a truly global event focusing on the burden of living with psoriasis. There are more than 125 million people with psoriasis/psoriatic arthritis in the world. Psoriasis is a severe chronic inflammatory disease that effects all ages, genders, races and ethnicities.
Biogen Idec today announced that the U.S. Patent and Trademark Office has granted U.S. Patent No. 8,399,514, which offers additional protection for TECFIDERA (dimethyl fumarate), the company's oral therapeutic candidate for the treatment of multiple sclerosis.
Mallinckrodt announced today that the first clinical data on MNK-795 will be presented at PAINWeek 2013, to be held September 4-7 in Las Vegas. MNK-795 is an extended-release oral formulation of oxycodone and acetaminophen that has been studied in clinical trials for the management of moderate to severe acute pain where the use of an opioid analgesic is appropriate.
On Feb. 27, 2018, I got an email from the Heritage Foundation, alerting me to a news conference that afternoon held by Republican attorneys general of Texas and other states. It was referred to only as a "discussion about the Affordable Care Act lawsuit."
› Verified 6 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Harris B Cohen, MD 345 N York Rd, Hatboro, PA 19040-2045 Ph: (215) 675-1516 | Harris B Cohen, MD 345 N York Rd, Hatboro, PA 19040-2045 Ph: (215) 675-1516 |
News Archive
October 29 is World Psoriasis Day. Conceived by patients for patients, World Psoriasis Day is a truly global event focusing on the burden of living with psoriasis. There are more than 125 million people with psoriasis/psoriatic arthritis in the world. Psoriasis is a severe chronic inflammatory disease that effects all ages, genders, races and ethnicities.
Biogen Idec today announced that the U.S. Patent and Trademark Office has granted U.S. Patent No. 8,399,514, which offers additional protection for TECFIDERA (dimethyl fumarate), the company's oral therapeutic candidate for the treatment of multiple sclerosis.
Mallinckrodt announced today that the first clinical data on MNK-795 will be presented at PAINWeek 2013, to be held September 4-7 in Las Vegas. MNK-795 is an extended-release oral formulation of oxycodone and acetaminophen that has been studied in clinical trials for the management of moderate to severe acute pain where the use of an opioid analgesic is appropriate.
On Feb. 27, 2018, I got an email from the Heritage Foundation, alerting me to a news conference that afternoon held by Republican attorneys general of Texas and other states. It was referred to only as a "discussion about the Affordable Care Act lawsuit."
› Verified 6 days ago
Dr. John Wilson, D.O. Family Medicine Medicare: Medicare Enrolled Practice Location: 509 Long Ln, Hatboro, PA 19040 Phone: 215-672-7197 | |
Dr. Lori Ann Truman-kraft, D.O. Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 345 N York Rd, Hatboro, PA 19040 Phone: 215-675-1516 Fax: 215-675-9176 | |
Dr. Rachel E Rosen, M.D. Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 345 N York Rd, Hatboro, PA 19040 Phone: 215-675-1516 Fax: 215-675-0901 | |
James D Judd, M.D. Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 345 N York Rd, Hatboro, PA 19040 Phone: 215-675-1516 Fax: 215-675-9176 | |
Thomas J Miller, M.D. Family Medicine Medicare: Not Enrolled in Medicare Practice Location: 345 N York Rd, Hatboro, PA 19040 Phone: 215-675-1516 Fax: 215-675-0901 | |
Dr. Stanley J Travis Jr., DO Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 501 Buckman Drive, Hatboro, PA 19040 Phone: 215-672-6878 Fax: 215-672-6812 |